Facilitating cross-border asset transactions for the Global Market.
We act as a bridge for pharmaceutical innovation. Whether bringing global assets into China or taking Chinese innovation to the world, we find the right match.
First-in-class or Best-in-class assets in Oncology, Autoimmune, and CNS.
High-barrier generics and 505(b)(2) modified release formulations.
Licensing opportunities not just for China, but for worldwide markets.